All news from Anaesthesiology

New Gene Therapy for Rare Form of Vision Loss Approved By FDA

Voretigene neparvovec-rzyl ( Luxturna , Spark Therapeutics) is targeted for adults and children with confirmed biallelic  RPE65  mutation-associated retinal dystrophy. The treatment, which is delivered surgically via subretinal injection , is the first gene therapy approved in the United States that targets a disease caused by mutations in a specific gene.

Palliative Care Underutilized in Dementia Patients with Surgical Abdomen

According to a new study published in the journal Surgery, patients with dementia who develop acute surgical abdomen have high rates of in-hospital mortality and non-routine discharge but rarely receive palliative care.Those who received surgical treatment were less likely to receive palliative care than those who didn’t have surgery, while outcomes were worse in surgical patients, the researchers found.